Omakomini Soft Capsule 2 grams (Omega-3 Fatty Acid Ethyl Ester 90)

Adult dose

Before administration, patients must undergo an appropriate lipid-lowering dietary regimen, which should continue throughout the treatment period. This medication should be taken with meals to avoid gastrointestinal disturbances. For hypertriglyceridemia, the usual initial dosage is 2g once a day, with a potential increase to 4g per day if necessary. Dosing can be done once or twice daily.

This drug should not be used by individuals who are allergic to any of its components or by children under the age of 18. Patients at high risk of bleeding due to severe trauma or surgery, patients with poor liver function, and individuals allergic to fish should exercise special caution when using this drug. Taking this medication may cause various side effects such as dyspepsia, rash, headache, dizziness, arthralgia, and shortness of breath; if any abnormal symptoms occur, a doctor should be consulted immediately. Before starting treatment, it is important to check triglyceride levels through a blood test and to follow a regimen of weight management, exercise, and dietary control. During the use of this drug, periodic blood tests should also be conducted to monitor triglyceride levels and liver function; treatment may be discontinued if no therapeutic effect is observed. Particularly, atrial fibrillation, a type of cardiac arrhythmia, may occur, so individuals with heart conditions or at heightened risk should use this medication more cautiously. Concomitant use with anticoagulants or aspirin may increase the risk of bleeding, so patients using these medications should inform their doctors. Women who are pregnant or breastfeeding should use this drug cautiously only when necessary, and ideally consult with a physician, as its safety is not established. In case of overdose, there are no specific antidotes; appropriate treatment and supportive care should be instituted according to symptoms. It is not recommended for children, especially those under 18, as safety and efficacy have not been established. Elderly patients aged 65 or older can use this drug, but caution is advised as the number of participants in clinical trials was small. This medication should be kept out of reach of children, and transferring it to another container should be avoided as it may cause accidents or quality degradation.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral or ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory distress accompanied by cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual impairments, paralysis, urination

Mild side effects

• Back pain
• cold symptoms
• infections
• pain
• angina
• dyspepsia
• belching
• rash
• taste disturbances
• abdominal bloating

This drug should be stored in a container that is tightly sealed to prevent air and moisture from entering. The storage temperature should be maintained below 25 degrees Celsius, and care should be taken not to freeze it.

Appearance

Transparent round soft capsules filled with yellowish oily substance, packed in aluminum foil pouches.

Package unit

30 pouches/box